Clinical Genomics Program Collaborations

Collaboration is a key element of the Clinical Genomics Program mission to accelerate scientific discovery related to the understanding, diagnosis, and treatment of genetically based immune disorders. The program cultivates both public and private collaborations with institutions and investigators from around the world in an effort to foster scientific discovery. Listed below are some of the institutions, companies, and partnerships developed among Clinical Genomics Program researchers:

  • Merck
  • Regeneron
  • Novartis
  • Broad
  • Cambridge
  • Yale
  • University of Michigan
  • Qatar Women and Children's Hospital
  • Kansas City Children's Mercy Hospital
  • Cincinnati Children's Hospital
  • Boston's Children's Hospital
  • University of Pennsylvania
  • Tubitak (Turkey)
  • University Hospitals in Ankara, Hacettepe, Marmara, and Istanbul

2018 Symposium

The Isil Barlan Symposium on Primary Immunodeficiency in Istanbul, Turkey, April 19-20, 2018

Content last reviewed on